InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-47.9%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Browse the complete record of transactions filed by O'Brien James Michael, Chief Financial Officer. Insider active across 1 company, notably Cognition Therapeutics INC. In total, 1 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €52k. History available since 13 October 2021. The latest transaction was filed on 13 October 2021 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to O'Brien James Michael
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
5,000 shares@ US$12.000.043% mcap50.0% of flowCommon StockSEC:0001104659-21-126361:0
Canonical exit: 11 Jan 2022 (T+90)
1 of 1 declaration
About O'Brien James Michael
James Michael O'Brien is the Chief Financial Officer at COGNITION THERAPEUTICS INC. He oversees the financial operations of the company, including risk management and strategic planning. James plays a key role in financial strategy and the company's growth.
